IFF Swings to $392M Loss on Goodwill Impairment, Sales Dip

Ticker: IFF · Form: 10-Q · Filed: Nov 4, 2025 · CIK: 51253

Sentiment: bearish

Topics: Goodwill Impairment, Net Loss, Sales Decline, Debt Reduction, Business Divestitures, Flavors and Fragrances, Specialty Ingredients

Related Tickers: IFF, SYF, ADM, DD

TL;DR

**IFF's massive goodwill impairment and sales drop are a red flag, but debt reduction from divestitures offers a glimmer of hope for a turnaround.**

AI Summary

INTERNATIONAL FLAVORS & FRAGRANCES INC. (IFF) reported a significant net loss of $392 million attributable to shareholders for the nine months ended September 30, 2025, a stark contrast to the net income of $323 million in the prior-year period. This downturn was primarily driven by a substantial goodwill impairment charge of $1,153 million in 2025, compared to $64 million in 2024, and a $108 million loss on assets classified as held for sale. Net sales decreased by 4.6% to $8,301 million for the nine months ended September 30, 2025, from $8,713 million in the same period of 2024. Despite the net loss, IFF generated $532 million in net cash from operating activities, down from $681 million in 2024, and saw a significant increase in net cash from investing activities to $2,426 million, largely due to $2,707 million in net proceeds from business disposals. The company also reduced its long-term debt from $7,564 million at December 31, 2024, to $4,741 million at September 30, 2025, partly aided by a $488 million gain on extinguishment of debt. Total assets decreased from $28,723 million to $25,768 million, while total shareholders' equity increased from $13,834 million to $14,241 million.

Why It Matters

IFF's substantial net loss of $392 million, primarily due to a $1,153 million goodwill impairment, signals significant challenges in its business segments and could impact investor confidence. The 4.6% decline in net sales suggests competitive pressures or softening demand in its core markets, affecting future revenue growth. However, the strategic divestitures, yielding $2,707 million in proceeds, and the subsequent reduction in long-term debt by over $2.8 billion, demonstrate a clear effort to streamline operations and strengthen the balance sheet, which could be a long-term positive for investors. Employees and customers might experience shifts in product focus or operational changes as the company realigns its portfolio in the competitive flavors, fragrances, and health & biosciences markets.

Risk Assessment

Risk Level: high — The company reported a net loss of $392 million for the nine months ended September 30, 2025, primarily due to a significant $1,153 million impairment of goodwill. This substantial impairment indicates a material decline in the expected future cash flows of certain acquired businesses, signaling underlying operational or market challenges. Additionally, net sales decreased by $412 million, or 4.6%, from $8,713 million in 2024 to $8,301 million in 2025, reflecting a weakening top-line performance.

Analyst Insight

Investors should closely monitor IFF's upcoming earnings calls for detailed explanations of the goodwill impairment and the performance of its remaining business segments. While the debt reduction is positive, the significant net loss and sales decline warrant caution; consider holding or reducing exposure until a clear path to sustained profitability and revenue growth is demonstrated.

Financial Highlights

debt To Equity
N/A
revenue
$8,301M
operating Margin
N/A
total Assets
$25,768M
total Debt
$4,741M
net Income
($392M)
eps
($1.53)
gross Margin
36.7%
cash Position
$621M
revenue Growth
-4.6%

Revenue Breakdown

SegmentRevenueGrowth
Food & BeverageN/AN/A
Home & Personal CareN/AN/A
Health & WellnessN/AN/A

Key Numbers

Key Players & Entities

FAQ

Why did INTERNATIONAL FLAVORS & FRAGRANCES INC. report a net loss in Q3 2025?

INTERNATIONAL FLAVORS & FRAGRANCES INC. reported a net loss of $392 million attributable to shareholders for the nine months ended September 30, 2025, primarily due to a significant $1,153 million impairment of goodwill. This impairment charge was a major factor in the swing from a net income of $323 million in the prior-year period.

How did IFF's net sales perform in the nine months ended September 30, 2025?

IFF's net sales decreased by 4.6% to $8,301 million for the nine months ended September 30, 2025, compared to $8,713 million in the same period of 2024. This represents a decline of $412 million year-over-year.

What was the impact of business disposals on IFF's cash flow?

Business disposals had a significant positive impact on IFF's cash flow from investing activities, generating $2,707 million in net proceeds for the nine months ended September 30, 2025. This contributed to a total net cash provided by investing activities of $2,426 million.

Did INTERNATIONAL FLAVORS & FRAGRANCES INC. reduce its debt in 2025?

Yes, INTERNATIONAL FLAVORS & FRAGRANCES INC. significantly reduced its long-term debt from $7,564 million at December 31, 2024, to $4,741 million at September 30, 2025. This reduction was aided by a $488 million gain on extinguishment of debt and net proceeds from business disposals.

What was the goodwill impairment amount for IFF in the nine months ended September 30, 2025?

The goodwill impairment recorded by IFF for the nine months ended September 30, 2025, was $1,153 million. This is a substantial increase compared to the $64 million impairment recorded in the same period of 2024.

How did IFF's operating profit change year-over-year?

IFF's operating profit swung from a profit of $639 million for the nine months ended September 30, 2024, to an operating loss of $479 million for the nine months ended September 30, 2025. This significant change is largely attributable to the $1,153 million goodwill impairment.

What is the current risk level for investing in IFF based on this 10-Q?

Based on this 10-Q, the risk level for investing in IFF is high. The company reported a substantial net loss of $392 million and a significant goodwill impairment of $1,153 million, indicating material challenges and a decline in asset value.

What were IFF's cash and cash equivalents at the end of September 30, 2025?

As of September 30, 2025, IFF's cash and cash equivalents stood at $621 million. This represents an increase from $469 million at December 31, 2024, and $569 million at September 30, 2024.

How much did IFF pay in cash dividends to shareholders for the nine months ended September 30, 2025?

INTERNATIONAL FLAVORS & FRAGRANCES INC. paid $306 million in cash dividends to shareholders for the nine months ended September 30, 2025. This is a decrease from $411 million paid in the same period of 2024.

What was the total shareholders' equity for IFF as of September 30, 2025?

As of September 30, 2025, IFF's total shareholders' equity was $14,241 million. This is an increase from $13,834 million reported at December 31, 2024.

Risk Factors

Industry Context

International Flavors & Fragrances Inc. (IFF) operates in the highly competitive global markets for food ingredients, fragrances, and health and biosciences. Key industry trends include increasing consumer demand for natural and sustainable products, evolving dietary preferences, and the need for innovative solutions in personal care and home products. The industry is characterized by consolidation and significant R&D investment to maintain a competitive edge.

Regulatory Implications

IFF operates under various regulatory frameworks globally, particularly concerning food safety, ingredient labeling, and environmental standards. Changes in these regulations, such as stricter ingredient approvals or sustainability mandates, could impact product development, manufacturing costs, and market access. Compliance with these evolving regulations is crucial for continued operations and market positioning.

What Investors Should Do

  1. Monitor the impact of the goodwill impairment on future earnings and strategic direction.
  2. Analyze the drivers behind the 4.6% decline in net sales and assess the sustainability of revenue streams.
  3. Evaluate the effectiveness of the debt reduction strategy and its impact on operational flexibility.
  4. Assess the company's ability to generate operating cash flow amidst declining sales and significant charges.

Key Dates

Glossary

Goodwill Impairment
A charge taken when the carrying value of goodwill on the balance sheet is deemed to be higher than its fair value, indicating that the acquired business has not performed as expected. (A significant $1,153 million impairment charge in 2025 heavily impacted IFF's net income, signaling issues with past acquisitions.)
Assets classified as held for sale
Assets that a company intends to sell in the near future. They are typically reported at the lower of their carrying amount or fair value less costs to sell. (IFF recorded a $108 million loss on these assets, indicating a strategic decision to divest underperforming or non-core assets.)
Gain on extinguishment of debt
A profit recognized when a company repays its debt for less than its carrying amount, often due to favorable market conditions or debt restructuring. (IFF recorded a $488 million gain, which helped reduce its overall debt burden.)
Net cash from operating activities
The cash generated or used by a company's normal business operations over a period. (A decrease to $532 million in 2025 from $681 million in 2024 suggests a potential weakening in the company's core cash-generating ability.)
Net proceeds from business disposals
The cash received from selling off a business unit or subsidiary, after deducting any transaction costs. (IFF received $2,707 million, significantly boosting its investing cash flow and aiding debt reduction.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, IFF has experienced a significant downturn, reporting a net loss of $392 million versus a net income of $323 million. This shift is largely attributable to a substantial goodwill impairment charge of $1,153 million in the current period, compared to $64 million previously. Net sales have also declined by 4.6%, indicating weaker market demand or increased competition. While total assets have decreased, reflecting asset disposals, shareholders' equity has seen a modest increase, partly due to debt reduction efforts.

Filing Stats: 4,822 words · 19 min read · ~16 pages · Grade level 16 · Accepted 2025-11-04 16:36:27

Filing Documents

- Financial Information

PART I - Financial Information

Financial Statements (Unaudited)

ITEM 1. Financial Statements (Unaudited) Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - Three and Nine Months Ended September 30, 2025 and 2024 1 Consolidated Balance Sheets - September 30, 2025 and December 31, 2024 2 Consolidated Statements of Shareholders' Equity - Three and Nine Months Ended September 30, 2025 and 2024 3 Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2025 and 2024 5

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 6

Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 40

Quantitative and Qualitative Disclosures about Market Risk

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 58

Controls and Procedures

ITEM 4. Controls and Procedures 58

- Other Information

PART II - Other Information

Legal Proceedings

ITEM 1. Legal Proceedings 59

Risk Factors

ITEM 1A. Risk Factors 59

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 59

Other Information

ITEM 5. Other Information 59

Exhibits

ITEM 6. Exhibits 59

Signatures

Signatures 60 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS. INTERNATIONAL FLAVORS & FRAGRANCES INC. CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, (DOLLARS AND SHARES IN MILLIONS EXCEPT PER SHARE AMOUNTS) 2025 2024 2025 2024 Net sales $ 2,694 $ 2,925 $ 8,301 $ 8,713 Cost of sales 1,711 1,873 5,253 5,569 Gross profit 983 1,052 3,048 3,144 Research and development expenses 174 162 520 501 Selling and administrative expenses 421 495 1,365 1,478 Amortization of acquisition-related intangibles 146 146 434 467 Impairment of goodwill — — 1,153 64 Restructuring and other charges 16 1 54 6 Losses (gains) on sale of assets — ( 1 ) 1 ( 11 ) Operating profit (loss) 226 249 ( 479 ) 639 Interest expense 48 74 180 236 Gain on extinguishment of debt — — ( 488 ) — Losses (gains) on business disposals — 20 111 ( 348 ) Loss on assets classified as held for sale 108 32 108 284 Other expense, net 14 28 44 44 Income (loss) before income taxes 56 95 ( 434 ) 423 Provision (benefit) for income taxes 15 36 ( 44 ) 96 Net income (loss) 41 59 ( 390 ) 327 Net income attributable to non-controlling interests 1 1 2 4 Net income (loss) attributable to IFF shareholders $ 40 $ 58 $ ( 392 ) $ 323 Net income (loss) per share - basic $ 0.16 $ 0.23 $ ( 1.53 ) $ 1.27 Net income (loss) per share - diluted $ 0.16 $ 0.23 $ ( 1.53 ) $ 1.27 Average number of shares outstanding - basic 256 256 256 255 Average number of shares outstanding - diluted 257 257 256 256 Net income (loss) $ 41 $ 59 $ ( 390 ) $ 327 Other comprehensive income (loss), after tax: Foreign currency translation adjustments ( 47 ) 555 1,115 134 Gains (losses) on derivatives qualifying as hedges — 1 ( 1 ) ( 5 ) Pension and postretirement liability adjustment ( 1 ) ( 1 ) ( 50 ) 7 Other comprehensive income (loss) ( 48 ) 555 1,064 136 Comprehensive income (loss) ( 7 ) 614 674 463 Comprehensi

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) NOTE 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations International Flavors & Fragrances Inc. and its subsidiaries (the "Registrant," "IFF," the "Company," "we," "us" and "our") is a leading creator and manufacturer of products for application in food, beverage, health & biosciences, scent (and pharmaceuticals, until the recent sale of our Pharma Solutions disposal group), as well as complementary adjacent products, including natural health ingredients, all of which are used in a wide variety of consumer and end-use products. Our products are sold principally to manufacturers of dairy, meat, beverages, snacks, savory, sweet, baked goods, grain processors and other foods, personal care products, soaps and detergents, cleaning products, perfumes, dietary supplements, food protection, infant, elderly and animal nutrition, functional food, bio-fuel, pharmaceutical and oral care products. As a result, we hold global leadership positions in the Food & Beverage, Home & Personal Care and Health & Wellness markets, and across key Tastes, Textures, Scents, Nutrition, Enzymes, Cultures, Soy Proteins, and Probiotics categories, among others. Basis of Presentation The accompanying interim Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes included in our 2024 Annual Report on Form 10-K ("2024 Form 10-K"), filed on February 28, 2025 with the Securities and Exchange Commission ("SEC"). The interim Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles ("GAAP") in the United States of America for interim financial information and with the rules and regulations for reporting on Form 10-Q, and are unaudited. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP in the United

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing